COMBINATION THERAPY WITH AN ANTI-CD25 ANTIBODY-DRUG CONJUGATE
The present disclosure relates to combination therapies for the treatment of pathological conditions, such as cancer. In particular, the present disclosure relates to combination therapies comprising treatment with an Antibody Drug Conjugate (ADC) and a secondary agent. La présente invention concern...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present disclosure relates to combination therapies for the treatment of pathological conditions, such as cancer. In particular, the present disclosure relates to combination therapies comprising treatment with an Antibody Drug Conjugate (ADC) and a secondary agent.
La présente invention concerne des polythérapies pour le traitement d'états pathologiques, tels que le cancer. En particulier, la présente invention concerne des polythérapies comprenant un traitement avec un Conjugué Anticorps-Médicament (CAM) et un agent secondaire. |
---|